Late adulthood mortality among African-American and white American people with Type 1 diabetes according to age at diabetes diagnosis
- PMID: 29532512
- PMCID: PMC5949256
- DOI: 10.1111/dme.13617
Late adulthood mortality among African-American and white American people with Type 1 diabetes according to age at diabetes diagnosis
Abstract
Aims: To estimate the overall and cause-specific mortality in a population of African-Americans and white Americans with a low socio-economic status who had young-onset insulin-treated diabetes and had survived beyond the age of 40 years, and to examine whether any excess risk varied according to age at diabetes onset.
Methods: Using the Southern Community Cohort Study, we conducted a mortality follow-up of a cohort of mostly low-income participants aged 40-79 years (mean 50 years) at cohort entry with insulin-treated diabetes diagnosed before age 30 years (n=475) and without diabetes (n=62 266). Childhood onset was defined as diabetes diagnosed before age 20 years (n=162), while young-adulthood onset was defined as diabetes diagnosed between ages 20 and 29 years (n=313). Cause-specific mortality was based on both underlying and contributing causes of death, obtained from death certificates. Multivariable Cox analysis was performed.
Results: During follow-up (mean 9.5 years), 38.7% of those with and 12.9% of those without diabetes died. Compared with those without diabetes, increases in mortality rate were generally similar among those with childhood- and young-adulthood-onset diabetes for deaths from: all causes (childhood: hazard ratio 4.3, CI 3.3-5.5; young adulthood: hazard ratio 4.9, CI 4.0-5.8); ischaemic heart disease (childhood: hazard ratio 5.7, CI 3.5-9.4; young adulthood: hazard ratio 7.9, CI 5.6-11.0); heart failure (childhood: hazard ratio 7.3, CI 4.2-12.7; young adulthood: hazard ratio 5.4, CI 3.3-8.9); sepsis (childhood: hazard ratio 10.3, CI 6.1-17.3; young adulthood: hazard ratio 8.8, CI 5.7-13.5); renal failure (childhood: hazard ratio 15.1, CI 8.6-26.5; young adulthood: hazard ratio 18.2, CI 12.3-27.1); respiratory disorders (childhood: hazard ratio 3.9, CI 2.3-6.7; young adulthood: hazard ratio 5.3, CI 3.7-7.7); suicide/homicide/accidents (childhood: hazard ratio 2.3, CI 0.72-7.0; young adulthood: hazard ratio 5.8, CI 3.4-10.2); and cancer (childhood: hazard ratio 2.1, CI 0.98-4.4; young adulthood: hazard ratio 1.2, CI 0.55-2.5).
Conclusions: We observed high excess long-term mortality for all-cause, renal failure, ischemic heart disease and heart failure mortality in African-American and white American people with early-onset insulin-treated diabetes.
© 2018 Diabetes UK.
Conflict of interest statement
None declared.
Figures



Similar articles
-
Cause-specific mortality by race in low-income Black and White people with Type 2 diabetes.Diabet Med. 2015 Jan;32(1):33-41. doi: 10.1111/dme.12563. Epub 2014 Sep 24. Diabet Med. 2015. PMID: 25112863 Free PMC article.
-
Excess mortality in Black compared with White patients with Type 1 diabetes: an examination of underlying causes.Diabet Med. 2005 Dec;22(12):1636-41. doi: 10.1111/j.1464-5491.2005.01671.x. Diabet Med. 2005. PMID: 16401305
-
Mortality and acute complications in children and young adults diagnosed with Type 1 diabetes in Yorkshire, UK: a cohort study.Diabet Med. 2018 Jan;35(1):112-120. doi: 10.1111/dme.13544. Diabet Med. 2018. PMID: 29111600
-
Age at menarche and risk of type 2 diabetes among African-American and white women in the Atherosclerosis Risk in Communities (ARIC) study.Diabetologia. 2012 Sep;55(9):2371-80. doi: 10.1007/s00125-012-2616-z. Epub 2012 Jul 4. Diabetologia. 2012. PMID: 22760786 Free PMC article.
-
Evaluation of type 1 diabetes in black African-heritage populations: no time for further neglect. Diabetes Epidemiology Research International Group.Diabet Med. 1992 Jul;9(6):513-21. doi: 10.1111/j.1464-5491.1992.tb01831.x. Diabet Med. 1992. PMID: 1643798 Review.
Cited by
-
Can Innovative Technologies Overcome HbA1c Disparity for African-American Youth with Type 1 Diabetes?J Diabetes Sci Technol. 2021 Sep;15(5):1069-1075. doi: 10.1177/19322968211021386. Epub 2021 Jun 17. J Diabetes Sci Technol. 2021. PMID: 34137288 Free PMC article.
-
Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections.Med. 2020 Dec 18;1(1):43-65. doi: 10.1016/j.medj.2020.06.008. Epub 2020 Jul 15. Med. 2020. PMID: 32838361 Free PMC article. Review.
-
Diabetes duration or age at onset and mortality in insulin-dependent diabetics: a systematic review and meta-analysis.Diabetol Metab Syndr. 2023 Jul 1;15(1):147. doi: 10.1186/s13098-023-01113-x. Diabetol Metab Syndr. 2023. PMID: 37393334 Free PMC article.
-
Advanced cardiovascular physiology in an individual with type 1 diabetes after 10-year ketogenic diet.Am J Physiol Cell Physiol. 2024 Aug 1;327(2):C446-C461. doi: 10.1152/ajpcell.00694.2023. Epub 2024 Jun 24. Am J Physiol Cell Physiol. 2024. PMID: 38912731 Free PMC article.
-
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study.Lancet. 2018 Aug 11;392(10146):477-486. doi: 10.1016/S0140-6736(18)31506-X. Epub 2018 Aug 9. Lancet. 2018. PMID: 30129464 Free PMC article.
References
-
- DERI Mortality Study Group. International analysis of insulin-dependent diabetes mortality: a preventative mortality perspective the Diabetes Epidemiology Research International (DERI) Study. Am J Epidemiol. 1995;142:612–618. - PubMed
-
- Skrivarhaug T, Bangstad H-J, Stene LC, Sandvik L, Hanssen K, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia. 2006;49:298–305. - PubMed
-
- Dahlquist G, Kallen B. Mortality in Childhood-Onset Type 1 Diabetes. Diabetes Care. 2005;28:2384–2387. - PubMed
-
- Nishimura R, LaPorte R, Dorman J, Tajima N, Becker D, Orchard T. Mortality Trends in Type 1 Diabetes: the Allegheny County (Pennsylvania) Registry 1965–1999. Diabetes Care. 2001;27:398–404. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical